Culture

Finding coronavirus's helper proteins

The researchers used a biophysical method called thermal proteome profiling (TPP) to gain a comprehensive overview of which human proteins are functionally altered during SARS-CoV-2 infection. TPP monitors protein amounts and denaturation temperatures - the points at which proteins heat up so much that they lose their 3D structure. A shift in denaturation temperature indicates that a particular protein has undergone a functional change upon infection, possibly due to the virus hijacking the protein for use in its own replication.

The scientists observed that infection with SARS-CoV-2 changed the abundance and thermal stability of hundreds of cellular proteins. This included thermal stability changes in proteins required to maintain the cytoskeleton - a protein network that maintains cell shape and stability - and a group of proteins called heat shock chaperones: proteins that take care of unfolded or misfolded proteins and help them to maintain their 3D structure.

Having identified candidate proteins and cellular processes that SARS-CoV-2 may hijack to promote its replication, the scientists used drugs to inhibit some of the host proteins that SARS-CoV-2 appeared to be exploiting. This resulted in a strong reduction in viral replication in the presence of two of the tested compounds, demonstrating their potential as antiviral therapeutics. The scientists believe that other proteins they identified could be targeted in a similar way to block SARS-CoV-2 proliferation.

The study was a collaborative effort, involving the Savitski team and Typas group in EMBL Heidelberg's Genome Biology Unit, EMBL's Proteomics Core Facility, the Beltrao group at EMBL's European Bioinformatics Institute (EMBL-EBI), the Boulant lab and colleagues from Heidelberg University Hospital, the German Cancer Research Center (DKFZ), and the Technical University of Munich. As well as gaining new insights into SARS-CoV-2 biology, the researchers were also able to expand the scope of the TPP methodology by adapting it to work with infectious samples under high biosafety conditions. This enables them to quickly analyse the effects of dangerous pathogens on the cell's proteins.

Credit: 
European Molecular Biology Laboratory

Predicting words' grammatical properties helps us read faster

image: Anastasiya Lopukhina, Research Fellow at the HSE Centre for Language and Brain

Image: 
Anastasiya Lopukhina

Psycholinguists from the HSE Centre for Language and Brain found that when reading, people are not only able to predict specific words, but also words' grammatical properties, which helps them to read faster. Researchers have also discovered that predictability of words and grammatical features can be successfully modelled with the use of neural networks. The study was published in the journal PLOS ONE.

The ability to predict the next word in another person's speech or in reading has been described by many psycho- and neurolinguistic studies over the last 40 years. It is assumed that this ability allows us to process the information faster. Some recent publications on the English language have demonstrated evidence that while reading, people can not only predict specific words, but also their properties (e.g., the part of speech or the semantic group). Such partial prediction also helps us to read faster.

In order to access predictability of a certain word in a context, researchers usually use cloze tasks, such as The cause of the accident was a mobile phone, which distracted the ______. In this phrase, different nouns are possible, but driver is the most probable, which is also the real ending of the sentence. The probability of the word driver in the context is calculated as the number of people who correctly guessed this word over the total number of people who completed the task.

The other approach for predicting word probability in context is the use of language models that offer word probabilities relying on a big corpus of texts. However, there are virtually no studies that would compare the probabilities received from the cloze task to those from the language model. Additionally, no one has tried to model the understudied grammatical predictability of words. The authors of the paper decided to learn whether native Russian speakers would predict grammatical properties of words and whether the language model probabilities could become a reliable substitution to probabilities from cloze tasks.

The researchers analysed responses of 605 native Russian speakers in the cloze task in 144 sentences and found out that people can precisely predict the specific word in about 18% of cases. Precision of prediction of parts of speech and morphological features of words (gender, number and case of nouns; tense, number, person and gender of verbs) varied from 63% to 78%. They discovered that the neural network model, which was trained on the Russian National Corpus, predicts specific words and grammatical properties with precision that is comparable to people's answers in the experiment. An important observation was that the neural network predicts low-probability words better than humans and predicts high-probability words worse than humans.

The second step in the study was to determine how experimental and corpus-based probabilities impact reading speed. To look into this, the researchers analysed data on eye movement in 96 people who were reading the same 144 sentences. The results showed that first, the higher the probability of guessing the part of speech, gender and number of nouns, as well as the tense of verbs, the faster the person read words with these features.

The researchers say that this proves that for languages with rich morphology, such as Russian, prediction is largely related to guessing words' grammatical properties.

Second, probabilities of grammatical features obtained from the neural network model explained reading speed as correctly as experimental probabilities. 'This means that for further studies, we will be able to use corpus-based probabilities from the language model without conducting new cloze task-based experiments,' commented Anastasiya Lopukhina https://www.hse.ru/en/staff/lopukhina, author of the paper and Research Fellow at the HSE Centre for Language and Brain.

Third, the probabilities of specific words received from the language model explained reading speed in a different way as compared to experiment-based probabilities. The authors assume that such a result may be related to different sources for corpus-based and experimental probabilities: corpus-based methods are better for low-probability words, and experimental ones are better for high-probability ones.

'Two things have been important for us in this work. First, we found out that reading native speakers of languages with rich morphology actively involve grammatical predicting,' Anastasiya Lopukhina said. 'Second, our colleagues, linguists and psychologists who study prediction got an opportunity to assess word probability with the use of language model: http://lm.ll-cl.org/. This will allow them to simplify the research process considerably'.

Credit: 
National Research University Higher School of Economics

Perceiving predators: Understanding how plants 'sense' herbivore attack

image: Recently, Professor Gen-ichiro Arimura from Tokyo University of Science, Japan, encapsulated the research on the herbivory-sensing mechanism of plants through elicitors. Commenting of the immense value of these elicitors, Prof. Arimura states, "This review focuses mainly on elicitors because they are timely, novel, and have potential biotechnological applications".

Image: 
Gen-ichiro Arimura, Tokyo University of Science

Nature has its way of maintaining balance. This statement rightly holds true for plants that are eaten by herbivores--insects or even mammals. Interestingly, these plants do not just silently allow themselves to be consumed and destroyed; in fact, they have evolved a defense system to warn them of predator attacks and potentially even ward them off. The defense systems arise as a result of inner and outer cellular signaling in the plants, as well as ecological cues. Plants have developed several ways of sensing damage; a lot of these involve the sensing of various "elicitor" molecules produced by either the predator or the plants themselves and initiation of an "SOS signal" of sorts.

In a recently published review in the journal Trends in Plant Science, Professor Gen-ichiro Arimura from Tokyo University of Science, Japan, encapsulates the research on the herbivory-sensing mechanism of plants through elicitors. Commenting of the immense value of these elicitors, Prof. Arimura states, "This review focuses mainly on elicitors because they are timely, novel, and have potential biotechnological applications".

When the same herbivorous animal comes to eat the plant multiple times, the plant learns to recognize its feeding behavior and records the "molecular pattern" associated with it. This is termed "herbivore-associated molecular patterns" or HAMPs. HAMPs are innate elicitors. Other plant elicitors include plant products present inside cells that leak out because of the damage caused by herbivory. Interestingly, when an herbivorous insect eats the plant, the digestion products of the plant cell walls and other cellular components become part of the oral secretions (OS) of the insect, which can also function as an elicitor!

Prof. Arimura highlights the fact that with the advancement of high-throughput gene- and protein-detecting systems, the characterization of elicitors of even specific and peculiar types of herbivores, such as those that suck cell sap and do not produce sufficient amounts of OS, has become possible. The proteins present in the salivary glands of such insects could be potential elicitors as they enter the plant during feeding. He explains, "RNA-seq and proteomic analyses of the salivary glands of sucking herbivores have led to the recent characterization of several elicitor proteins, including a mucin-like salivary protein and mite elicitor proteins, which serve as elicitors in the leaves of the host plants upon their secretion into plants during feeding."

The review also highlights some peculiar elicitors like the eggs and pheromones of insects that plants can detect and initiate a defense response against. In some special cases, the symbiotic bacteria living inside the insect's gut can also regulate the defense systems of the plants.

And now that we have understood different types of elicitors, the question remains--what signaling mechanisms do the plants use to communicate the SOS signal?

So far, it has been hypothesized that the signaling is made possible by proteins transported through the vascular tissue of plants. Interestingly, there is evidence of airborne signaling across plants, by a phenomenon called "talking plants." Upon damage, plants release volatile chemicals into the air, which can be perceived by neighboring plants. There is also evidence of epigenetic regulation of defense systems wherein plants maintain a sort of "genetic memory" of the insects that have attacked them and can fine-tune the defense response accordingly for future attacks.

Given the improvement in knowledge of the mechanisms of plant defense systems, we can embrace the possibility of a "genetic" form of pest control that can help us circumvent the use of chemical pesticides, which, with all their risks, have become a sort of "necessary evil" for farmers. This could usher in modern, scientifically sound ways of organic farming that would free agricultural practices from harmful chemicals.

Credit: 
Tokyo University of Science

A boost for plant research

image: With two additional genes for the enzyme dioxygenase and the light-controlled anion channel ACR1, the tobacco plant can channel salt ions across the cell membrane when exposed to green light. The success can be seen in the experiment: While pollen tubes normally grow in the direction of the egg cell for fertilization, in genetically modified cells they change the direction of growth depending on the exposure to light.

Image: 
Graphic: Dr. Kai Konrad

It is almost ten years since the scientific journal Science called optogenetics the "breakthrough of the decade". Put simply, the technique makes it possible to control the electrical activity of cells with pulses of light. With its help, scientists can gain new insights into the functioning of nerve cells, for example, and thus better understand neurological and psychiatric diseases such as depression and schizophrenia.

Established procedure on animal cells

In research on animal cells, optogenetics is now an established technique used in many fields. The picture is different in plant research: transferring the principle to plant cells and applying it widely has not been possible until now.

However, this has now changed: Scientists at the Julius Maximilians University of Würzburg (JMU) have succeeded in applying optogenetic methods in tobacco plants. They present the results of their work in the current issue of the journal Nature Plants. "In particular, Dr. Kai Konrad from Prof. Hedrich's group (Botany I) and Dr. Shiqiang Gao from my group were mainly responsible for the success of this project" explains Professor Georg Nagel, co-founder of optogenetics. In addition to the Department of Neurophysiology in the Institute of Physiology, three chairs of the Julius-von-Sachs Institute were involved in the collaboration: Botany I, Botany II and Pharmaceutical Biology.

Light switch for cell activity

"Optogenetics is the manipulation of cells or living organisms by light after a 'light sensor' has been introduced into them using genetic engineering methods. In particular, the light-controlled cation channel channelrhodopsin-2 has helped optogenetics achieve a breakthrough," says Nagel, describing the method he co-developed. With the help of channelrhodopsin, the activity of cells can be switched on and off as if with a light switch.

In plant cells, however, this has so far only worked to a limited extent. There are two main reasons for this: "It is difficult to genetically modify plants so that they functionally produce rhodopsins. In addition, they lack a crucial cofactor without which rhodopsins cannot function: all-trans retinal, also known as vitamin A," explains Dr. Gao.

Green light for plant cells

Prof. Nagel, Dr. Gao, Dr. Konrad, and colleagues have now been able to solve both problems. They have succeeded in producing vitamin A in tobacco plants by means of an introduced enzyme from a marine bacterium, thus enabling improved incorporation of rhodopsin into the cell membrane. This allows, for the first time, non-invasive manipulation of intact plants or selected cells by light via the so-called anion channel rhodopsin GtACR1.

In an earlier approach, plant physiologists from Botany I had artificially added the much-needed cofactor vitamin A to cells to allow a light-gated cation channel to become active in plant cells (Reyer et al., 2020, PNAS). Using the genetic trick now presented, Prof. Nagel and colleagues have generated plants that produce a special enzyme in addition to a rhodopsin, called dioxygenase. These plants are then able to produce vitamin A - which is normally not present in plants - from provitamin A which is abundant in the plant chloroplast. The combination of vitamin A production and optimization of rhodopsins for plant application ultimately led the researchers led by Prof. Nagel, Dr. Konrad and Dr. Gao to success.

New approach for plant research

"If you irradiate these cells with green light, the permeability of the cell membrane for negatively charged particles increases sharply, and the membrane potential changes significantly," explains Dr. Konrad. In this way, he says, it is possible to specifically manipulate the growth of pollen tubes and the development of leaves, for example, and thus to study the molecular mechanisms of plant growth processes in detail. The Würzburg researchers are confident that this novel optogenetic approach to plant research will greatly facilitate the analysis of previously misunderstood signaling pathways in the future.

A pioneer of optogenetics

Rhodopsin is a naturally light-sensitive pigment that forms the basis of vision in many living organisms. The fact that a light-sensitive ion pump from archaebacteria (bacteriorhodopsin) can be incorporated into vertebrate cells and function there was first demonstrated by Georg Nagel in 1995 together with Ernst Bamberg at the Max Planck Institute for Biophysics in Frankfurt. In 2002/2003, this proof was then also achieved with light-sensitive ion channels from algae.

Together with Peter Hegemann, Nagel demonstrated the existence of two light-sensitive channel proteins, channelrhodopsin-1 and channelrhodopsin- 2 (ChR1/ChR2), in two papers published in 2002 and 2003. Crucially, the researchers discovered that ChR2 elicits an extremely rapid, light-induced change in membrane current and membrane voltage when the gene is expressed in vertebrate cells. In addition, ChR2's small size makes it very easy to use.

Nagel has since then received numerous awards for this discovery, most recently in 2020 - together with two other pioneers of optogenetics - the $1.2 million Shaw Prize for Life Sciences.

Credit: 
University of Würzburg

Unexpected findings on weight loss and breast cancer from international study in JNCCN

image: JNCCN February 2021 Cover

Image: 
NCCN

PLYMOUTH MEETING, PA [February 16, 2021] -- New research in the February 2021 issue of JNCCN--Journal of the National Comprehensive Cancer Network examined body mass index (BMI) data for people with HER2-positive early breast cancer, and found a 5% weight loss in patients over two years in was associated with worse outcomes. Weight gain over the same time period did not affect survival rates.

"The finding that weight loss, and not weight gain, was associated with worse outcomes is unexpected," said lead researcher Samuel Martel, MD, Universitè de Sherbrooke, Quebec, Canada, who worked with researchers in Belgium, Brazil, Germany, Italy, Switzerland, and the United Kingdom, as well as the National Cancer Institute and the Mayo Clinic in the United States. "We were unable to make a distinction between intentional versus unintentional weight loss, so it's a matter of speculation whether worse outcomes were due to weight loss, or vice versa. We hope our findings highlight the importance of incorporating consecutive and prolonged data collection on weight in oncology trials, and gaining greater understanding of the metabolic processes after cancer diagnosis that may impact outcomes."

The BMI data came from the ALTTO BIG 2-06 trial, which collected height and weight data in 8,381 patients with HER2-positive early breast cancer treated with chemotherapy plus trastuzumab and/or lapatinib. 2.2% were underweight at the start of treatment, 45.3% were normal weight, 32.1% were classified as overweight, with another 20.4% obese--defined as a BMI greater than 30. Initial obesity was associated with worse outcomes, including more frequent and serious adverse events leading to treatment discontinuation, as well as significantly worse overall survival rates.

"It was surprising to see that more than 5% weight loss at 2 years was associated with poorer distant disease-free survival. Is our general advice to obese/overweight patient to exercise and lose weight wrong?" questioned Anthony D. Elias, MD, University of Colorado Cancer Center, a member of the NCCN Clinical Practice Guidelines (NCCN Guidelines®) Panel for Breast Cancer. "Careful examination of the Kaplan-Meier hazard plots suggests that the relapse curves for those with weight loss are steeper in the second and third years of follow-up, but thereafter are relatively parallel. It's possible that the weight loss observed early may be an indication for impending relapse of breast cancer."

The study highlights the importance of weight management in cancer survivorship. The authors hope their findings may provide the basis for further research and oncology trials to guide weight control during the survivorship period.

Credit: 
National Comprehensive Cancer Network

High public support for strict COVID measures but lower level of trust in gov

High levels of public support for strict measures to control COVID-19 during the first wave of the pandemic did not reflect high levels of public trust in the UK government's honesty, transparency or motives, suggests a new study published in PLOS One.

The 'mixed-methods' project, a collaboration between the London School of Hygiene & Tropical Medicine (LSHTM) and University College London (UCL), involved collecting data from more than 9,000 adults living in the UK using an online survey.

It found that during the first wave of COVID-19 (April 2020) 95% of participants were in support of the government having powers to enforce behaviour change. However, only around half (52%) thought that the government was actually doing a good job of controlling COVID-19. Even fewer (36%) thought the government "always or mostly" told the truth about COVID-19.

The study brought together scientists from many disciplines including outbreak specialists, anthropologists, data scientists and epidemiologists. The team asked people to talk about their experiences of lockdown in their own words and then, using sophisticated machine learning approaches, identified where participants talked about topics that related to trust and transparency.

The team's social scientists then read the responses to piece together how people's attitudes towards lockdown related to their perspectives on how trustworthy, truthful and transparent they felt the UK government was being about COVID-19 and the response.

Against a backdrop of relatively low opinions of the UK government's honesty and transparency, the team was surprised to find many of the study's participants still supported the implementation of strict measures to force people to comply with control guidelines. Many even said that they felt there were times when it was justifiable, or even necessary for the government to be less than fully open.

Dr Luisa Enria, Assistant Professor at LSHTM and primary author of the study, said: "In times of crisis and insecurity, citizens may be willing to accept lower levels of transparency for the sake of national security. But if this is a crisis effect that is driven by sudden dramatic changes and a climate of fear and uncertainty, then this is not something that the government can necessarily rely on in the long term to maintain confidence in, and support for control guidelines."

Previous work by Dr Enria and the study's co-lead investigator Professor Shelley Lees has shown that the success of outbreak responses is closely linked to the strength of public trust.

Professor Lees from LSHTM said: "Our work in communities affected by Ebola Virus in West Africa and DR Congo has shown that if the public doesn't trust the people leading the response, and if there are perceptions that those leaders lack transparency and honesty; then this can hamper control of the infection."

The project also looked at how levels of trust differed among communities from around the UK. Compared with those living in London, Scottish respondents had significantly lower levels of trust, whilst people from the West Midlands, East and South East of England all had significantly higher levels of trust.

Groups that had lower levels of household income, or who had higher levels of education such as a degree, were each around half as likely to trust the government as people at the other ends of the spectrum. Among the 48% of respondents who felt that the government was not making good decisions, a significant majority (60%) felt that the economy was being prioritised. Only around 5% thought that people and their health were the main priority for the government.

In the group who thought that the government was doing well, those figures were very different (respectively 10% and 32%). Despite efforts to distribute the survey to black and minority ethnic groups, the study team had a very low response and cautioned that further work was needed to understand issues of trust among members of these and other minority communities.

Dr Enria said: "Many of our respondents expressed concerns about the extent to which scientific evidence was really being used to guide policy. The consistency of communications from the government, the lack of insight into how policy decisions were being made, and about what were the government's real motivations, were also concerns of many people surveyed.

"These are questions we've come to hear a lot over the last year, but they were already being asked a year ago at the beginning of wave one."

The research team recommend that the UK government should develop targeted community engagement measures and tailor their messaging and public discussion to the realities faced by particular groups across the political, social and economic divides.

In contrast to the centralised and top-down communication so far, the team believes that this approach could directly address the diversity of experiences and perspectives that exist across the country, and help to maintain support and adherence to government guidelines.

Dr Chrissy Roberts, Associate Professor at LSHTM and the study's co-lead investigator, said: "We know from the lessons of past epidemics that public consent for control measures, meaning the willingness of people to follow the rules, can just evaporate when trust is gone. The government can't depend on crisis effects forever, nor ignore the hard to reach groups when trying to encourage good infection prevention and control behaviours.

"They have to gain the trust of every group. This means reaching out to, opening dialogues with, and engaging in constructive collaborations with people and communities outside their normal sphere of political and social influence."

The authors acknowledge limitations of the study, including that the survey was not population representative, meaning that the findings could not be generalised across all communities and demographic groups in the UK. There was over-representation of white, female and more highly educated people in the survey and significant under-representation of black, Asian and minority ethnic people. The study team emphasised the importance of exploring the political consequences of epidemic control measures in the contexts of structural inequality and lack of equity for ethnic and cultural minorities.

Credit: 
London School of Hygiene & Tropical Medicine

Study sheds light on how people cope with health challenges and medical debt

A recent qualitative study sheds light on how people cope with health and financial challenges, highlighting the important role that communication plays in these coping strategies.

"This is one of the first studies to look at how people respond to the combination of financial uncertainties and health uncertainties," says Lynsey Romo, first author of the study and an associate professor of communication at North Carolina State University. "And it drives home that uncertainty about money and uncertainty about health go hand in hand. Financial limitations created significant health challenges - such as an inability to afford prescription medications. And health problems created significant expenses leading to serious financial challenges.

"The study also highlights that these challenges span income levels. You can have a good job, good insurance, do everything 'right' and still find yourself struggling due to the nature of the healthcare system in the U.S."

For the study, researchers conducted in-depth interviews of 17 U.S. adults. All were white; 14 identified as women. Study participants had medical debt ranging from less than $10,000 to more than $150,000. Salaries also ranged from less than $10,000 to more than $150,000. The health problems that resulted in financial struggles included conditions such as cancer, cystic fibrosis and stroke.

The researchers found that health-related financial uncertainty had significant adverse consequences for the physical and mental health of many study participants. For example, many interviewees reported experiencing symptoms of emergent depression and other mental health issues related to their health conditions and related financial challenges.

As one study participant noted: "It gets to the point where [the financial uncertainty] just weighs against you. Like, am I worth doing this procedure?...I'll never make this much money. I'm never going to be able to pay this off."

The researchers discovered a range of strategies that study participants utilized to manage their uncertainty.

"Many of these strategies revolved around communication," Romo says. "Seeking information and emotional support from your social network is inherently about communication. Seeking financial help or help in getting to medical appointments is about communication. Advocating for yourself or others in the context of medical care is all about communication. So being able to share information effectively is incredibly important."

Other strategies for managing uncertainty involved making sacrifices - and provided clear examples of the impact that uncertainty can have on physical health.

For example, study participants reported buying less food in order to afford medication; being unable to afford medications at all; taking less medication than a doctor prescribed in order to make it last longer; being unable to attend health appointments due to cost.

"Qualitative studies, like this one, are important," Romo says. "There are lots of statistics about how many people are struggling with medical debt. I remember seeing survey data from early last year showing that more than 30% of U.S. workers carry medical debt - and that was looking at people with jobs, before the pandemic.

"Qualitative studies give us a fuller understanding of what those numbers mean in real-world terms. What effect does this combination of financial and health uncertainty have on people? And how do they deal with it? Our study suggests that the effect is profound. The pandemic, and related expenses, may make it worse. And this is something we need to be looking at."

Credit: 
North Carolina State University

Application of potassium to grass used as cover crop guarantees higher-quality cotton

image: Besides simplifying operational logistics and improving production, fertilization of the grass used as a cover crop can reduce fertilizer use in the long run

Image: 
Vinícius Peres

By Maria Fernanda Ziegler | Agência FAPESP – The use of cover crops between cotton harvests protects the soil, conserves water, and reduces the risk of erosion. Researchers at the University of Western São Paulo (UNOESTE) and São Paulo State University (UNESP) in Brazil found that application of potassium (K) to a grass cover crop grown before cotton in sandy soil lowered production cost and resulted in cotton with a higher market value.

“The dynamics of early application of potassium to grass planted as a cover crop before cotton results in more resistant fibers and a smaller proportion of short fibers than when the conventional method of applying the nutrient to the cotton crop is used. In addition to the improvement in quality, the technique reduces production cost for the farmer because of its impact on operational dynamics. The farmer can apply potassium once instead of twice. The technique saves labor and diesel oil, as well as optimizing operational logistics. In the long run, it’s also expected to reduce fertilizer use,” said Fábio Echer, a professor at UNOESTE and lead author of an article on the study published in Scientific Reports.

The two-year study, which was conducted on UNOESTE’s experimental farm, compared the conventional method of fertilizing cotton directly with two other methods, both involving early application of potassium. It also evaluated cotton growing without fertilizer and without a cover crop.

The research was funded by a master’s scholarship awarded by FAPESP to Vinicius José Souza Peres. The São Paulo State Cotton Growers Association (APPA) and Fundação Agrisus also collaborated on the project.

Quantitative and qualitative analysis of fiber

In one of the treatments, the researchers applied potassium to the grass cover crop in two doses (70 kg per hectare each). They compared this with application to the cover crop of a single dose of 140 kg per hectare and split application, with half going to the cover crop and the other half to the cotton. The results in terms of fiber yield were identical to those of the conventional method. Yield and quality were both lower with no fertilizer than when the conventional method or early application was used.

“The study included a calculation of fertilizer use efficiency,” Echer told Agência FAPESP. “We found that early application enabled the forage grass used as a cover crop to recover nutrients from the soil, in addition to the function of protecting it. This plant has a deep rhizosphere and its roots are able to find soil nutrients lost via leaching from previous crops, recycling them, and pushing them back to the surface. When the plant dries out, it releases potassium in the first rain to the crops that come next.”

The main advantage of early application, however, is that it increases the commercial value of the cotton produced. The analysis of fiber quality and cotton value found that fertilizing the cover crop with potassium led to a smaller proportion of short fibers, which depreciate the finished product, and also enhanced fiber fineness (micronaire), maturity and strength. “These characteristics are important. They represent higher commercial value for the production of finer cotton fabric, which is better quality and fetches a higher price on the market,” Echer said.

The improvement in quality relates to the availability of potassium in the soil and plant water status. “Cotton fiber is a cell, and like all cells it needs water to expand. By conserving more water in the soil and in the plant, we can also improve fiber size,” he explained.

Potassium plays a key role in the control of plant water loss. It regulates stomata functioning, carbon dioxide fixation, enzyme activation, and nutrient transport, as well as aiding stress tolerance. Soil potassium reaches plant roots mainly by diffusion, which accounts for 72%-96% of each plant’s requirement.

“Extreme weather events, high temperatures, and droughts have become more frequent because of global warming, and conservationist soil management techniques such as those suggested by the study can mitigate the adverse effects of all this on production,” Echer said. “Inconsistent rainfall may limit crop viability, and because only about 8% of Brazil’s cotton plantations are irrigated, the use of a cover crop is especially important. Straw mulch helps reduce soil temperature, which in turn helps conserve water.”

In western São Paulo, where the experimental farm used in the study is located, the temperature can reach 70°C on cotton plantations without a cover crop (and hence with exposed soil). The use of a cover crop keeps the soil at about 28°C-30°C, conserving soil moisture.

Early application of potassium is widely used in plantations with clayey soil, Echer added, but the technique had not yet been tested on sandy soil with little organic matter, making nutrient retention harder. “Farmers were reluctant to apply fertilizer early in the case of crops planted in sandy soil,” he said. “The study proves that applying potassium to the cover crop maintains yield and improves fiber quality even in sandy soil, which is more fragile, stores less water and makes potassium more susceptible to leaching.”

According to the researchers, the method analyzed in western São Paulo can be replicated in cotton plantations with sandy soil in Mato Grosso (the leading cotton producer in Brazil) and Bahia, as well as in other countries. “The cover crop can be different from the one we used in this study, because the climate may be different, but a precedent has been set for testing new cover species in other parts of the world,” Echer said.

The article “Potassium application to the cover crop prior to cotton planting as a fertilization strategy in sandy soils” (doi: 10.1038/s41598-020-77354-x) by Fábio Rafael Echer, Vinicius José Souza Peres and Ciro Antonio Rosolem can be read at: www.nature.com/articles/s41598-020-77354-x.

Journal

Scientific Reports

DOI

10.1038/s41598-020-77354-x

Credit: 
Fundação de Amparo à Pesquisa do Estado de São Paulo

First test for all known human coronaviruses, including new SARS-CoV-2 variants

Scientists at the Center for Infection and Immunity (CII) at Columbia University Mailman School of Public Health and SunYat-Sen University in China have set the stage for the development of highly sensitive antibody tests for infection with all known human coronaviruses, including new variants of SARS-CoV-2. These tests should also allow differentiation of immune responses due to infection and vaccination. The research is published in Communications Biology, a Nature journal.

The HCoV-Peptide array developed by CII scientists consists of 3 million immune markers on a glass chip, covering proteins of all known human coronaviruses, including the SARS-CoV-2. In collaboration with a team at Sun Yat-Sen University, the CII researchers identified 29 immune signatures specific to SARS-CoV-2. These genetic fingerprints (peptides) provide the blueprint for tests that will be used for diagnostics and surveillance. Current antibody tests for SARS-CoV-2 infection may generate false positive results because of cross-reactivity with seasonal coronaviruses responsible for the common cold, as well as MERS-CoV and SARS-CoV-1.

To develop the HCoV-Peptide array, the researchers first analyzed blood samples taken from individuals with asymptomatic, mild, or severe SARS-CoV-2 infections, and controls including healthy individuals and those exposed to SARS-CoV-1 and seasonal coronaviruses. An analysis of all ~170,000 peptides related to known human coronaviruses yielded 29 peptides with the strongest and most specific reactivity with SARS-CoV-2. Next, they validated their test using a second set of blood samples, including those from confirmed cases of SARS-CoV-2, those with antibodies to other human coronaviruses, and healthy individuals.

The new test has a 98 percent specificity and sensitivity. Immune signatures were present from eight days after onset of COVID-19 symptoms to as long as six to seven months after infection.

"This work will allow us and others to build inexpensive, easy to use blood tests that can provide data for exposure as well as immunity," says author Nischay Mishra, PhD, assistant professor of epidemiology at the Columbia Mailman School.

"This work with our colleagues at SunYat-Sen, led by Professor Jiahai Lu, and with Nimble Therapeutics, underscores the importance to public health of global collaboration and partnerships with industry in addressing the challenges of the COVID-19 pandemic," says senior and corresponding author W. Ian Lipkin, MD, director of CII.

Previously, the researchers have used similar methods to develop tests for Zika, acute flaccid myelitis, and tick-borne infections.

Credit: 
Columbia University's Mailman School of Public Health

A genetic variant inherited from Neanderthals reduces the risk of severe COVID-19

image: New research has found that a group of genes that reduces the risk of developing severe COVID-19 by around 20% is inherited from Neanderthals

Image: 
Bjorn Oberg, Karolinska Institutet.

New research has found that a group of genes that reduces the risk of developing severe COVID-19 by around 20% is inherited from Neanderthals

These genes, located on chromosome 12, code for enzymes that play a vital role in helping cells destroy the genomes of invading viruses

The study suggests that enzymes produced by the Neanderthal variant of these genes are more efficient which helps protect against severe COVID-19

This genetic variant was passed to humans around 60,000 years ago via interbreeding between modern humans and Neanderthals

The genetic variant has increased in frequency over the last millennium and is now found in around half of people living outside Africa

SARS-CoV-2, the virus that causes COVID-19, impacts people in different ways after infection. Some experience only mild or no symptoms at all while others become sick enough to require hospitalization and may develop respiratory failure and die.

Now, researchers at the Okinawa Institute of Science and Technology Graduate University (OIST) in Japan and the Max Planck Institute for Evolutionary Biology in Germany have found that a group of genes that reduces the risk of a person becoming seriously ill with COVID-19 by around 20% is inherited from Neanderthals.

"Of course, other factors such as advanced age or underlying conditions such as diabetes have a significant impact on how ill an infected individual may become," said Professor Svante Pääbo, who leads the Human Evolutionary Genomics Unit at OIST. "But genetic factors also play an important role and some of these have been contributed to present-day people by Neanderthals."

Last year, Professor Svante Pääbo and his colleague Professor Hugo Zeberg reported in Nature that the greatest genetic risk factor so far identified, doubling the risk to develop severe COVID-19 when infected by the virus, had been inherited from Neanderthals.

Their latest research builds on a new study, published in December last year from the Genetics of Mortality in Critical Care (GenOMICC) consortium in the UK, which collected genome sequences of 2,244 people who developed severe COVID-19. This UK study pinpointed additional genetic regions on four chromosomes that impact how individuals respond to the virus.

Now, in a study published today in PNAS, Professor Pääbo and Professor Zeberg show that one of the newly identified regions carries a variant that is almost identical to those found in three Neanderthals - a ~50,000-year-old Neanderthal from Croatia, and two Neanderthals, one around 70,000 years old and the other around 120,000 years old, from Southern Siberia.

Surprisingly, this second genetic factor influences COVID-19 outcomes in the opposite direction to the first genetic factor, providing protection rather than increasing the risk to develop severe COVID-19. The variant is located on chromosome 12 and reduces the risk that an individual will require intensive care after infection by about 22%.

"It's quite amazing that despite Neanderthals becoming extinct around 40,000 years ago, their immune system still influences us in both positive and negative ways today," said Professor Pääbo.

To try to understand how this variant affects COVID-19 outcomes, the research team took a closer look at the genes located in this region. They found that three genes in this region, called OAS, code for enzymes that are produced upon viral infection and in turn activate other enzymes that degrade viral genomes in infected cells.

"It seems that the enzymes encoded by the Neanderthal variant are more efficient, reducing the chance of severe consequences to SARS-CoV-2 infections," Professor Pääbo explained.

The researchers also studied how the newly discovered Neanderthal-like genetic variants changed in frequency after ending up in modern humans some 60,000 years ago.

To do this, they used genomic information retrieved by different research groups from thousands of human skeletons of varying ages.

They found that the variant increased in frequency after the last Ice Age and then increased in frequency again during the past millennium. As a result, today it occurs in about half of people living outside Africa and in around 30% of people in Japan. In contrast, the researchers previously found that the major risk variant inherited from Neanderthals is almost absent in Japan.

"The rise in the frequency of this protective Neanderthal variant suggests that it may have been beneficial also in the past, maybe during other disease outbreaks caused by RNA viruses," said Professor Pääbo.

Credit: 
Okinawa Institute of Science and Technology (OIST) Graduate University

Neandertal gene variants both increase and decrease the risk for severe COVID-19

image: Hugo Zeberg, researcher at the Department of Neuroscience, Karolinska Institutet, and the Max Planck Institute for Evolutionary Anthropology.

Image: 
Hugo Zeberg

Last year, researchers at Karolinska Institutet in Sweden and the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany showed that a major genetic risk factor for severe COVID-19 is inherited from Neandertals. Now the same researchers show, in a study published in PNAS, that Neandertals also contributed a protective variant. Half of all people outside Africa carry a Neandertal gene variant that reduces the risk of needing intensive care for COVID-19 by 20 percent.

Some people become seriously ill when infected with SARS-CoV-2 while others get only mild or no symptoms. In addition to risk factors such as advanced age and diabetes, gene variants also make people more or less sensitive to developing severe COVID-19. A major genetic risk factor is located on chromosome 3 and dramatically increases the risk of respiratory failure and even death. Hugo Zeberg and Svante Pääbo at Karolinska Institutet and the Max Planck Institute for Evolutionary Anthropology discovered last year that this risk variant is inherited from Neandertals.

Now the research duo shows that the Neandertals also contributed a protective variant to present-day people. They find that a region on chromosome 12 that reduces the risk of needing intensive care upon infection with the virus by 20 percent is inherited from Neandertals. The genes in this region are called OAS and regulate the activity of an enzyme that breaks down viral genomes, and the Neandertal variant of the enzyme seems to do this more efficiently.

"This shows that our heritage from Neandertals is a double-edged sword when it comes to our response to SARS-CoV-2. They have given us variants that we can both curse and thank them for," says Hugo Zeberg, researcher at the Department of Neuroscience, Karolinska Institutet, and the Max Planck Institute for Evolutionary Anthropology.

The study also shows that the protective variant from Neandertals has increased in frequency since the last Ice Age so that it is now carried by about half of all people outside Africa.

"It is striking that this Neandertal gene variant has become so common in many parts of the world. This suggests that it has been favourable in the past," says Svante Pääbo, director at the Max Planck Institute for Evolutionary Anthropology. "It is also striking that two genetic variants inherited from Neandertals influence COVID-19 outcomes in opposite directions. Their immune system obviously influences us in both positive and negative ways today."

Credit: 
Karolinska Institutet

Fixer-upper: Understanding the DNA repair toolkit to chart cancer evolution

image: Studying the intricacies of DNA repair mechanisms may help us understand cancer evolution better, and even provide us the weapons to fight cancer.

Image: 
Cancer Biology & Medicine

The ongoing fight of science against cancer has made great strides, but cancer cells have not made it easy. The complexity of cancer cells and their adaptive evolutionary nature complicate the search for effective cures. Multiple DNA repair pathways in healthy cells typically work to rectify DNA damages caused by sources within the organism, like spontaneous DNA mutations, or from outside, like ultraviolet radiation.

But what happens when these pathways malfunction? It is known that deficiencies in these pathways increase the instability of the genes, and this causes cancer to develop. Therefore, detailed knowledge of how DNA repair pathways participate in this process is crucial for tracking tumor progression, understanding the emergence of drug resistance, and developing efficient therapeutic interventions.

To this end, a group of scientists from China examined five critical DNA repair pathways and their impact on cancer evolution by reviewing the findings of the latest published research. "Different types of DNA damages have corresponding repair pathways to efficiently fix them," says Dr. Jiadong Wang, associated with Peking University Health Science Center and a member of the research team. "So, it is not surprising that particularly defective DNA repair pathways are associated with specific cancers."

They first looked at the mismatch repair system, which eliminates spontaneous mutations to ensure accurate DNA replication. A deficiency in this system, it was found, causes microsatellite instability (MSI), wherein nucleotides, the building-block components of DNA, are either longer or shorter in crucial genes, compared to the normal size, and continue replicating beyond their limit. MSI is clinically associated with 10-15% of colorectal, ovarian, endometrial, and gastric cancers.

Next on their checklist was the nucleotide excision repair (NER) pathway, which recognizes and repairs a wide range of structurally unrelated DNA lesions caused by DNA structural damage. Besides increasing the risk of bladder and breast cancers, an NER deficiency can cause Cockayne syndrome and xeroderma pigmentosum, an ultraviolet light-induced genetic disorder that causes many types of skin cancer.

The base excision repair (BER) pathway, on the other hand, repairs DNA "base lesions" that inhibit cell growth. These lesions are caused by spontaneous DNA decay and external factors like radiation and cytostatic drug treatment. BER pathway components and their deficiency are associated with a high risk of lung, pancreatic, and breast cancers.

Double-strand breaks (DSBs), caused by DNA replication or ionizing radiation, can lead to point mutations, chromosomal rearrangements, and cell death. Two pathways exist to repair DSBs--homologous recombination (HR) and non-homologous end joining. The inactivation of DSB repair genes is closely associated with cancer, and a large fraction of hereditary breast, ovarian, and prostate cancers is caused by BRCA1 and BRCA2 mutations--which are key players in the HR pathway.

Lastly, the scientists discussed the interstrand crosslink (ICL) repair pathway. ICLs, formed from aldehydes and chemotherapy drugs within the body, block essential cellular processes like replication and transcription. They are repaired by the Fanconi anemia (FA) pathway; a defect in this pathway leads to genomic instability, bone marrow failure, and an increased risk of breast and ovarian cancers.

The review combines all these findings, previously scattered across different research papers, and takes them ahead to discuss clinical interventions that could address such pathway damage. Many potential suggestions, ranging from the use of chromatin-modifying agents to the combined application of chemotherapy/radiotherapy with immune checkpoint blockade therapy, have been suggested.

Dr. Ning Zhang, another member of the team, is optimistic that knowing more about DNA repair pathways could be one of the elusive keys to curing cancer. "Specifically, the relationship between DNA repair pathways and cancer evolution need to be explored, because we have seen how closely connected the two are," he says.

Cancer has persisted for so long because of its resilient strategies to live on despite the best efforts of medicine. Perhaps this close look at the role of DNA repair pathways will arm us with another valuable weapon in the fight against cancer.

Credit: 
Cactus Communications

Antibody-based COVID-19 treatments work best in concert with immune cells

Of the nine treatments and preventives for COVID-19 authorized for emergency use by the Food and Drug Administration, three are drugs made from so-called monoclonal antibodies. Such drugs provide patients with ready-made antibodies that neutralize the virus, bypassing the body's slower and sometimes less effective process of making its own antibodies.

But such therapies were developed without detailed information about how antibodies interact with the rest of the immune system during COVID-19. Faced with a new, deadly and fast-spreading disease, drug designers started work without knowing whether antibodies' ability to activate a variety of immune cells would aid or hinder efforts to control the disease. Such abilities are collectively known as antibody effector functions.

A new study from researchers at Washington University School of Medicine in St. Louis has shown that antibody effector functions are a crucial part of effectively treating infections with SARS-CoV-2 -- the virus that causes COVID-19 -- but are dispensable when the antibodies are used to prevent infection. The findings, available online in the journal Cell, could help scientists improve the next generation of antibody-based COVID-19 drugs.

"Some of the companies removed the effector functions from their antibodies, and other companies are trying to optimize the effector functions," said senior author Michael S. Diamond, MD, PhD, the Herbert S. Gasser Professor of Medicine. "Neither of these strategies is backed by data in the context of SARS-CoV-2 infections. Based on our findings, if you have a potently neutralizing antibody without effector functions and you give it before infection, as a preventive, it will probably work. But if you give it after infection, it won't work well; you need to optimize effector functions to get maximal benefit."

Antibodies are shaped like the letter Y. The tips of the two short arms are almost infinitely changeable, giving antibodies the ability to recognize virtually any molecular shape. The short arms attach to foreign molecules and target them for clearance. The long arm is where the effector functions are located. It attaches to receptors on immune cells, inducing them to kill infected cells and release molecules that sculpt the immune response.

But this process can go wrong. In a process known as antibody-dependent enhancement, interactions between the long arm of antibodies and immune cells can worsen some viral infections, notably infections with the tropical dengue virus. People who have antibodies against one strain of dengue virus are at risk of developing life-threatening dengue fever if they become infected with another strain of the virus.

To avoid the danger of antibody-dependent enhancement, some companies developing antibody-based COVID-19 drugs changed the sequence in the long arm of the antibodies to prevent it from interacting with immune cells. Other companies took the opposite tack: strengthening antibody effector functions to potentially boost the potency of their drugs.

To determine the role of antibody effector functions in COVID-19, Diamond and colleagues, including first author Emma Winkler, an MD/PhD student in Diamond's lab, and co-senior author James E. Crowe Jr., MD, of Vanderbilt University Medical Center, started with an antibody that is very effective at recognizing and neutralizing SARS-CoV-2. They eliminated the antibody's effector functions by mutating its long arm so that it could not stimulate immune cells.

The researchers gave separate groups of mice the original or the mutated SARS-CoV-2 antibodies, or a placebo antibody that does not recognize SARS-CoV-2. The antibodies were given to the animals one day before they were infected through the nose with the virus that causes COVID-19. Regardless of whether the effector functions of the antibodies were intact, the SARS-CoV-2 antibodies protected the mice against disease. Mice that had received either of the SARS-CoV-2 antibodies lost less weight and had lower levels of virus in their lungs than the ones that received the placebo antibody. Importantly, there was no sign of antibody-dependent enhancement of disease.

Then, the researchers investigated whether antibody effector functions are needed for treatment after infection. They gave mice the virus that causes COVID-19 and treated them one, two or three days later with the original or mutated SARS-CoV-2 antibodies, or a placebo antibody. Compared to the placebo, the original SARS-CoV-2 antibody protected mice against weight loss and death, but the one without effector functions did not.

Further experiments with different antibodies with and without effector functions, and in a different animal -- hamsters -- yielded the same result: Effector functions are an indispensable part of effective antibody treatment for COVID-19.

Some antibody-based drugs for COVID-19 are being developed as preventives for use in high-risk environments such as nursing homes. But most such drugs are geared toward treating people who are already infected. For that purpose, optimizing antibody effector functions could be the key to making a powerful drug, Diamond said. As part of this study, the researchers discovered that the loss of effector functions changed the kinds of immune cells that were recruited to fight the infection and how they behaved.

"'Effector functions' refers to a complex set of interactions between antibodies and other elements of the immune system," said Diamond, who also is a professor of molecular microbiology and of pathology & immunology. "You can introduce different point mutations to augment certain kinds of effector functions, and some might be harmful to the immune response while others might be beneficial. There's a lot of nuance. We are still learning how to harness effector functions so you get what you want but not what you don't want."

Credit: 
Washington University School of Medicine

Star employees get most of the credit - and blame

ITHACA, N.Y. - Working with a "star" employee - someone who demonstrates exceptional performance and enjoys broad visibility relative to industry peers - offers both risks and rewards, according to new research from the Cornell University's ILR School.

In collaborations, stars tend to get more than their share of the credit when things go well - and more of the blame when projects don't succeed, according to "Shadows and Shields: Stars Limit Their Collaborators' Exposure to Attributions of Both Credit and Blame," published Dec. 10, 2020, by Personnel Psychology.

"We look at what happens when you collaborate with a star in terms of whose getting credit when that collaboration is successful," said Rebecca Kehoe, associate professor of human resource studies. "What we find, and this is consistent with research on the Matthew effect and other work, is that if you collaborate with a star and that collaboration is successful, the star does get more of that credit and you benefit less than if you were working with somebody that wasn't a star. The silver lining here though is that if you collaborate with a star and that collaboration is not successful, the star takes the heat."

Looking at the U.S. hedge fund industry, Kehoe and her co-author, F. Scott Bentley of Binghamton University, hypothesized two-way interactions predicting that collaboration with a star would weaken both the positive effect of co-managed fund success and the negative effect of co-managed fund failure on a non-star.

The duo also examined the role a non-star's personal status plays in shaping the effects of succeeding or failing with a star co-manager. Namely, if a non-star has success of their own, they may be less likely to be overshadowed by a star co-manager when they succeed, and be better poised to benefit from shifts of blame to a star co-manager if they fail.

The paper "really points to the richness that stars can provide to an organization if they, and the people around them, are managed effectively," Kehoe said.

Kehoe and Bentley tested their hypotheses using data obtained from Eurekahedge, a private third-party investment research firm specializing in compiling data on hedge funds and fund managers, and from Institutional Investor, a media organization known for its trade journal that publishes lists ranking hedge fund firms and fund managers.

Their data consisted of monthly observations on U.S. hedge funds from 2005 to 2019 and career histories of the managers of these funds. The full dataset included information on 59,337 non-star fund managers involved in the management of 28,304 funds.

Results showed that collaborating with a star reduces the credit - and gains in professional status - that non-stars experience in the context of collaborative success. On the other hand, collaborating with a star not only mitigates - but may actually outweigh - the professional status loss associated with collaborative failure.

The duo also found that people who don't do well on their own but have a successful collaboration with a star, actually fare worse.

"They may be seen as riding the coattail of the stars," Kehoe said. "While low-performing employees might not get a status bump when they succeed with a star, if they're at least in a situation where they're learning from the star's expertise, then that's going to help their performance outside the collaboration, which can eventually put them in a better position down the line.

"I think what this points to, both for low-performing employees and for managers," she said, "is the importance of being very mindful of what is the gain that you're hoping to achieve from a collaboration with a star."

Credit: 
Cornell University

New discovery may enable accurate prediction of cancer spread before cancer develops

The researchers analysed cells, mouse models, and human patient samples using biochemical, mathematical, and biophysical methods. They identified a protein present in the mesh-like membrane structure (the basement membrane) associated with tumour and vessel softness, and good survival of cancer patients. The researchers tested if removing this protein from the basement membrane would enhance the spread of cancer, which it did, and if supply of this protein would reduce cancer spread, which it did. They proceeded to show that the levels of this protein (netrin-4) already present in basement membrane of organs may determine cancer spread even before cancer develops, in several cancer types.

"These are extremely exciting findings that open up the possibility to predict which organs a person's cancer most probably spread to before they even have cancer. This information therefore has the potential to guide and improve cancer patient treatment and care." said Professor Janine Erler, senior researcher on the paper.

In their study, the researchers could show for the first time the impact of basement membrane composition on its mechanical properties thereby affecting cancer cell transmigration over this protein border within the inter-cellular space. They identified the secreted protein netrin-4 to open nodes inside the basement membrane network, which simultaneously softens the basement membrane and increases its mesh (pore) size. This unexpected finding highlights that cancer cell movement is dominantly controlled by the basement membrane stiffness and pore size plays an underpart. Thus, the more netrin-4 inside the basement membrane of the primary tumour or inside blood vessels within organs prone to metastasis, the less metastasis, impacting on patient survival. Moreover, they demonstrate for the first time that the mechanical properties of the basement membrane independent of cancer-related modifications are a pivotal determinant of cancer patient survival.

"We were incredibly excited to find a mechanistic explanation for our observations where the theoretical modelling closely matched our experimental data. We could show that the more netrin-4 molecules present, the softer the basement membrane and the more difficult for a cell to traverse this membrane thereby keeping cells contained in one area. We are currently exploring the therapeutic and diagnostic potential of our findings. Our study is a result of a huge collaboration effort from researchers in Denmark, Sweden, Germany, the UK, and Belgium, spanning many disciplines, which has been key to obtaining the exciting results." added Dr Raphael Reuten, lead researcher on the study.

Historically, there has been much focus on the stiffness of the extracellular matrix that lies outside of cells and the influence on cancer progression. However, there have not been studies investigating the influence of basement membrane stiffness. Moreover, studying the impact of mechanical properties of the basement membrane on cell invasion and cancer metastasis has not been possible so far. The mechanistic insights into netrin-4 activity inside basement membranes has enabled the researchers to bridge this gap of knowledge and present new opportunities to study basement membrane stiffness in a broad range of biological processes.

Credit: 
University of Copenhagen - The Faculty of Health and Medical Sciences